IBCC - Instituto Brasileiro de Controle do Câncer-Centro de Pesquisa Clínica (Site 0200)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Cervical cancer

Running trials

• Active, not recruiting

  A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)

  NCT06459180· Phase 3· Merck Sharp & Dohme LLC· Source